| 03/31/2026 3:10 PM | Briacell Therap (1610820) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 1:40 PM | Briacell Therap (1610820) Subject Nasdaq Stock Market LLC (1354457) Filed by | Form 25-NSE | |
| 01/23/2026 5:59 PM | Briacell Therap (1610820) Subject CITADEL ADVISORS LLC (1423053) Filed by | Form SCHEDULE 13G | |
| 01/15/2026 3:15 PM | Briacell Therap (1610820) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:15 PM | Briacell Therap (1610820) Filer | Form 424B4 | |
| 01/13/2026 11:15 PM | Briacell Therap (1610820) Filer | Form EFFECT | |
| 01/13/2026 7:57 PM | Briacell Therap (1610820) Filer | Form S-1MEF | |
| 01/13/2026 4:13 PM | Briacell Therap (1610820) Filer | Form CERT | |
| 01/13/2026 11:07 AM | Briacell Therap (1610820) Filer | Form 8-A12B | |
| 12/23/2025 8:06 AM | Briacell Therap (1610820) Subject | Form FWP | |
| 12/23/2025 7:21 AM | Briacell Therap (1610820) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for BCTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Briacell Therap and its competitors with MarketBeat's FREE daily newsletter.
|
| 11/28/2025 7:15 PM | Briacell Therap (1610820) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/07/2025 3:47 PM | Briacell Therap (1610820) Subject CVI Investments, Inc. (1649553) Filed by | Form SCHEDULE 13G/A | |
| 10/15/2025 7:46 PM | Briacell Therap (1610820) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 10/10/2025 11:31 AM | Briacell Therap (1610820) Subject Plambeck Jeremy Myung Jae (2090655) Filed by | Form SCHEDULE 13G | |
| 08/25/2025 7:18 PM | Briacell Therap (1610820) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/28/2025 10:38 AM | Briacell Therap (1610820) Subject Iroquois Capital Management, LLC (1481867) Filed by | Form SCHEDULE 13G | |
| 07/21/2025 10:16 AM | Briacell Therap (1610820) Subject CVI Investments, Inc. (1649553) Filed by | Form SCHEDULE 13G/A | |
| 07/16/2025 3:15 PM | Briacell Therap (1610820) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2025 8:18 PM | Briacell Therap (1610820) Filer | Form 424B4 | |
| 07/15/2025 11:15 PM | Briacell Therap (1610820) Filer | Form EFFECT | |
| 07/10/2025 4:29 PM | Briacell Therap (1610820) Filer | Form S-1/A | |
| 07/09/2025 12:05 PM | Briacell Therap (1610820) Filer | Form S-1/A | |
| 07/08/2025 3:46 PM | Briacell Therap (1610820) Subject | Form FWP | |
| 07/08/2025 3:08 PM | Briacell Therap (1610820) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 06/18/2025 7:27 AM | Briacell Therap (1610820) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2025 3:34 PM | Briacell Therap (1610820) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2025 8:08 PM | 3i, LP (1841619) Filed by Briacell Therap (1610820) Subject | Form SCHEDULE 13G/A | |